Transfusion-related acute lung injury: incidence and risk factors

Author:

Toy Pearl1,Gajic Ognjen2,Bacchetti Peter1,Looney Mark R.1,Gropper Michael A.1,Hubmayr Rolf2,Lowell Clifford A.1,Norris Philip J.13,Murphy Edward L.13,Weiskopf Richard B.1,Wilson Gregory2,Koenigsberg Monique1,Lee Deanna1,Schuller Randy4,Wu Ping1,Grimes Barbara1,Gandhi Manish J.2,Winters Jeffrey L.2,Mair David4,Hirschler Nora15,Sanchez Rosen Rosa13,Matthay Michael A.1,

Affiliation:

1. University of California–San Francisco, San Francisco, CA;

2. Mayo Clinic, Rochester, MN;

3. Blood Systems Research Institute, San Francisco, CA;

4. American Red Cross Neutrophil Reference Laboratory, St Paul, MN; and

5. Blood Centers of the Pacific, San Francisco, CA

Abstract

Abstract Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk factors by a case-control study, 2 academic medical centers enrolled 89 cases and 164 transfused controls. Recipient risk factors identified by multivariate analysis were higher IL-8 levels, liver surgery, chronic alcohol abuse, shock, higher peak airway pressure while being mechanically ventilated, current smoking, and positive fluid balance. Transfusion risk factors were receipt of plasma or whole blood from female donors (odds ratio = 4.5, 95% confidence interval [CI], 1.85-11.2, P = .001), volume of HLA class II antibody with normalized background ratio more than 27.5 (OR = 1.92/100 mL, 95% CI, 1.08-3.4, P = .03), and volume of anti–human neutrophil antigen positive by granulocyte immunofluoresence test (OR = 1.71/100 mL, 95% CI, 1.18-2.5, P = .004). Little or no risk was associated with older red blood cell units, noncognate or weak cognate class II antibody, or class I antibody. Reduced transfusion of plasma from female donors was concurrent with reduced TRALI incidence: 2.57 (95% CI, 1.72-3.86) in 2006 versus 0.81 (95% CI, 0.44-1.49) in 2009 per 10 000 transfused units (P = .002). The identified risk factors provide potential targets for reducing residual TRALI.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference50 articles.

1. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009 Annual Summaries 2010 Accessed February 2, 2011 http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm204763.htm

2. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination.;Bernard;Am J Respir Crit Care Med,1994

3. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel.;Kleinman;Transfusion,2004

4. Transfusion-related acute lung injury: defini-ion and review.;Toy;Crit Care Med,2005

5. Adult respiratory distress syndrome: risk with common predispositions.;Fowler;Ann Intern Med,1983

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3